These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 36248993)

  • 1. Clinical applications of circulating tumor-derived DNA in the management of gastrointestinal cancers - current evidence and future directions.
    Lam RCT; Johnson D; Lam G; Li MLY; Wong JWL; Lam WKJ; Chan KCA; Ma B
    Front Oncol; 2022; 12():970242. PubMed ID: 36248993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices.
    Malla M; Loree JM; Kasi PM; Parikh AR
    J Clin Oncol; 2022 Aug; 40(24):2846-2857. PubMed ID: 35839443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ctDNA to Guide Adjuvant Therapy in Localized Colorectal Cancer (CRC).
    Masfarré L; Vidal J; Fernández-Rodríguez C; Montagut C
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34201274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)-Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC).
    Chakrabarti S; Kasi AK; Parikh AR; Mahipal A
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ctDNA MRD Detection and Personalized Oncogenomic Analysis in Oligometastatic Colorectal Cancer From Plasma and Urine.
    Pellini B; Pejovic N; Feng W; Earland N; Harris PK; Usmani A; Szymanski JJ; Qaium F; Mudd J; Petty M; Jiang Y; Singh A; Maher CA; Henke LE; Park H; Ciorba MA; Kim H; Mutch MG; Pedersen KS; Tan BR; Hawkins WG; Fields RC; Chaudhuri AA
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34250420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Circulating Tumor DNA in Gastrointestinal Cancers: Current Knowledge and Perspectives.
    Moati E; Taly V; Garinet S; Didelot A; Taieb J; Laurent-Puig P; Zaanan A
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Emerging Role of Circulating Tumor DNA in Non-Colorectal Gastrointestinal Cancers.
    Lee MS; Kaseb AO; Pant S
    Clin Cancer Res; 2023 Sep; 29(17):3267-3274. PubMed ID: 37092904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer.
    Shields MD; Chen K; Dutcher G; Patel I; Pellini B
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of circulating tumour DNA analysis for gastrointestinal cancers.
    Nakamura Y; Shitara K
    ESMO Open; 2020 Jan; 5(Suppl 1):e000600. PubMed ID: 32830648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mind the target: circulating tumour DNA in gastrointestinal malignancies.
    Fontana E; Ignatova E
    Curr Opin Oncol; 2022 Jul; 34(4):395-402. PubMed ID: 35837709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State of the Art: ctDNA in Upper Gastrointestinal Malignancies.
    Labiano I; Huerta AE; Arrazubi V; Hernandez-Garcia I; Mata E; Gomez D; Arasanz H; Vera R; Alsina M
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer.
    Reece M; Saluja H; Hollington P; Karapetis CS; Vatandoust S; Young GP; Symonds EL
    Front Genet; 2019; 10():1118. PubMed ID: 31824558
    [No Abstract]   [Full Text] [Related]  

  • 13. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
    Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
    Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor genomic profiling and personalized tracking of circulating tumor DNA in Vietnamese colorectal cancer patients.
    Nguyen HT; Nguyen TV; Nguyen Hoang VA; Tran DH; Le Trinh NA; Le MT; Nguyen Tran TA; Pham TH; Dinh TC; Nguyen TS; Nguyen The KC; Mai H; Chu MT; Pham DH; Nguyen XC; Ngo Ha TM; Nguyen DS; Nguyen DQ; Lu YT; Do Thi TT; Truong DK; Nguyen QT; Nguyen HN; Giang H; Tu LN
    Front Oncol; 2022; 12():1069296. PubMed ID: 36578946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer.
    Arisi MF; Dotan E; Fernandez SV
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal residual disease monitoring via ctDNA: a case report of Lynch syndrome with synchronous colorectal cancer and review of literature.
    Eslinger C; Wu C; Ahn DH
    J Gastrointest Oncol; 2024 Jun; 15(3):1341-1347. PubMed ID: 38989405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular residual disease detection in resected, muscle-invasive urothelial cancer with a tissue-based comprehensive genomic profiling-informed personalized monitoring assay.
    Powles T; Young A; Nimeiri H; Madison RW; Fine A; Zollinger DR; Huang Y; Xu C; Gjoerup OV; Aushev VN; Wu HT; Aleshin A; Carter C; Davarpanah N; Degaonkar V; Gupta P; Mariathasan S; Schleifman E; Assaf ZJ; Oxnard G; Hegde PS
    Front Oncol; 2023; 13():1221718. PubMed ID: 37601688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.
    Tie J; Wang Y; Cohen J; Li L; Hong W; Christie M; Wong HL; Kosmider S; Wong R; Thomson B; Choi J; Fox A; Field K; Burge M; Shannon J; Kotasek D; Tebbutt NC; Karapetis C; Underhill C; Haydon A; Schaeffer J; Ptak J; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
    PLoS Med; 2021 May; 18(5):e1003620. PubMed ID: 33939694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor DNA in early-stage colon cancer: ready for prime time or needing refinement?
    Solar Vasconcelos JP; Boutin M; Loree JM
    Ther Adv Med Oncol; 2022; 14():17588359221143975. PubMed ID: 36570410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers.
    Toor OM; Ahmed Z; Bahaj W; Boda U; Cummings LS; McNally ME; Kennedy KF; Pluard TJ; Hussain A; Subramanian J; Masood A
    Mol Cancer Ther; 2018 May; 17(5):1123-1132. PubMed ID: 29500272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.